Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease

2025/02/19 by Mia Jensen, Boye L. Jensen · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Acute Kidney Injury Research #Adenosine and Purinergic Signaling #Nitric Oxide and Endothelin Effects

paper · doi:10.1016/j.kint.2024.12.011

openalex publication_date 2025/02/19 · crossref created 2025/02/19 · crossref issued 2025/03/01 · crossref published 2025/03/01 · crossref published-print 2025/03/01 · crossref deposited 2025/06/26 · openalex created_date 2025/10/10 · crossref indexed 2026/02/27 · openalex updated_date 2026/07/28

Citations

• Soluble GC stimulators and activators: Past, present and future
• Hiperparatireoidismo secundário à hipovitaminose D depende dos níveis séricos de magnésio
• Activating soluble guanylyl cyclase attenuates ischemic kidney damage

Discussions

• Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease doi.org/10.1016/j.kint.2024.12.011 Original article: doi.org/10.1016/j.kint.2024.10.025 #KIComment [bsky, 3 points, 0 comments]